BioPharma Drug Discovery
XtalPi's Ailux Biologics Enters License Agreement with Janssen Biotech for AI-Driven Biologics Discovery Platform
XtalPi, a global leader in AI drug discovery, announced a license agreement between Ailux Biologics, a division of XtalPi Inc., and Janssen Biotech, I...
October 14, 2024 | News
Dizal Receives Fourth Breakthrough Therapy Designation for Sunvozertinib in EGFR Exon20ins NSCLC
Fourth Breakthrough Therapy Designation for sunvozertinib in NSCLC with EGFR exon20ins Dizal (SSE:688192), a biopharmaceutical company committed to d...
October 14, 2024 | News
Leading Drug Discovery CRO NovAliX Partners with Bruker to Transform Therapeutic Innovation
Bruker Acquires Minority Stake in NovAliX in Strategic Move Partnership Leverages Synergies Between Premium Drug Discovery CRO and High-Value Life Scien...
October 11, 2024 | News
Genentech's Itovebi™ Wins FDA Approval for HR-Positive Breast Cancer, Doubling Progression-Free Survival in PIK3CA-Mutated Cases
– Approval is based on Phase III INAVO120 results, showing the ItovebiTM (inavolisib)-based regimen more than doubled progression-free sur...
October 11, 2024 | News
Daewoong Pharmaceutical Showcases Cutting-Edge Microneedle Drug Delivery Technology at CPHI Worldwide 2024
Daewoong Pharmaceutical (Co-CEOs Seongsoo Park and Chang-jae Lee) announced on the 9th that they will present their cutting-edge drug delivery te...
October 10, 2024 | News
Ciconia Bioventures Launched as Joint Venture to Drive Global Drug Discovery from Japan
Ciconia Bioventures Inc. (Representative Director, Founder CEO: Toshio Fujimoto, "Ciconia") announced its establishment as a joint venture compan...
October 09, 2024 | News
Innovent Biologics and ASK Pharm Announce Strategic Partnership to Commercialize Limertinib for EGFR-Mutated Lung Cancer in China
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...
October 08, 2024 | News
Ascentage Pharma’s APG-2449 Tyrosine Kinase Inhibitor Cleared for Two Registrational Phase III Studies in NSCLC Patients
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet med...
October 08, 2024 | News
Synexa Life Sciences Acquires Alderley Analytical Ltd, Strengthening Bioanalytical Capabilities and Expanding European Reach
Synexa Life Sciences, a specialist biomarker and bioanalysis service provider, announces the acquisition of Alderley Analytical Ltd, based near ...
October 08, 2024 | News
Thermo Fisher Scientific Launches Accelerator™ Drug Development: Transforming Drug Development with Comprehensive CDMO and CRO Services
Company Launches Accelerator™ Drug Development, 360° Contract Development and Manufacturing Organization (CDMO) and Contract Research Organizatio...
October 07, 2024 | News
ABL Bio Partners with MSD to Evaluate ABL103 and KEYTRUDA® Combo in Advanced Solid Tumor Clinical Trial
ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, today announced that it has entered into a clinical trial collaboration ...
October 07, 2024 | News
Eisai Expands Direct Presence in Saudi Arabia with New Pharmaceutical Sales Subsidiary
Eisai announced the commencement of full-scale operations at Eisai Pharmaceuticals Single Person Limited Liability Company (Eisai Saudi Arabia), a wholly-o...
October 02, 2024 | News
Akeso's Cadonilimab Gains Approval for First-Line Treatment of Advanced Gastric Cancer in China
Akeso (9926. HK) announced that its internally developed PD-1/CTLA-4 bispecific antibody, cadonilimab, has received approval from the National Medical Prod...
October 01, 2024 | News
Innovent Biologics' New Drug Application for Picankibart Accepted by China's NMPA for Treatment of Moderate to Severe Plaque Psoriasis
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...
September 27, 2024 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
